Literature DB >> 28131967

The role of therapeutic hypothermia in the management of acute spinal cord injury.

Nikolay L Martirosyan1, Arpan A Patel2, Alessandro Carotenuto2, M Yashar S Kalani3, Michael A Bohl4, Mark C Preul3, Nicholas Theodore5.   

Abstract

This review paper investigates the history, efficacy, and administration of systemic and local hypothermia for spinal cord injury (SCI). It summarizes the published experimental and clinical evidence on hypothermia for SCI and analyzes the potential for further research. Early experimental animal research showed that local hypothermia improved recovery and gain of function after acute SCI. However, in the early 1970s, clinical research findings did not coincide with results of these animal trials, which led to a loss of interest in local hypothermia. Since the 1980s, systemic hypothermia has been successfully used to treat SCI in both animals and humans. An abundance of positive evidence suggests that clinical trials are needed to determine the effectiveness of hypothermia for SCI. As a first step, we investigated the published clinical and experimental evidence on the use of hypothermia for SCI patients, who have few available treatment options. We searched PubMed for English-language reports published from 1940 to 2016 containing terms related to SCI treatment using hypothermia. We reviewed all articles on local hypothermia and acute SCI or on systemic hypothermia and acute SCI. Bibliographies of retrieved publications were also screened for additional citations. Ninety-six papers were selected. The clinical use of hypothermia is most successful if applied according to certain optimized parameters (e.g., duration, temperature, time from injury to initiation of cooling, and rewarming time). Preliminary data suggest that modest systemic hypothermia applied for 48h provides the best therapeutic value, but the parameters for use of local hypothermia vary greatly. Experimental evidence and some clinical evidence suggest that both local hypothermia and systemic hypothermia are beneficial for acute SCI. Future research should focus on defining the optimal levels of parameters. Large, multicenter, controlled clinical trials are needed to investigate its therapeutic potential.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acute spinal cord injury; Circulatory arrest; Endovascular cooling; Hypothermia; Hypothermia, local; Ischemia; Systemic

Mesh:

Year:  2017        PMID: 28131967     DOI: 10.1016/j.clineuro.2017.01.002

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  11 in total

1.  Therapeutic systemic hypothermia for a pediatric patient with an isolated cervical spinal cord injury.

Authors:  Jonathan H Pelletier; Courtney H Mann; Benjamin T German; Jefferson G Williams; Mark Piehl
Journal:  J Spinal Cord Med       Date:  2018-09-19       Impact factor: 1.985

2.  A Direct Comparison of Physical Versus Dihydrocapsaicin-Induced Hypothermia in a Rat Model of Traumatic Spinal Cord Injury.

Authors:  Amrita Sarkar; Kevin T Kim; Orest Tsymbalyuk; Kaspar Keledjian; Bradley E Wilhelmy; Nageen A Sherani; Xiaofeng Jia; Volodymyr Gerzanich; J Marc Simard
Journal:  Ther Hypothermia Temp Manag       Date:  2021-10-07       Impact factor: 1.369

Review 3.  Therapeutic Hypothermia and Neuroprotection in Acute Neurological Disease.

Authors:  Kota Kurisu; Jong Youl Kim; Jesung You; Midori A Yenari
Journal:  Curr Med Chem       Date:  2019       Impact factor: 4.530

4.  Cold protection allows local cryotherapy in a clinical-relevant model of traumatic optic neuropathy.

Authors:  Mengyun Li; Bo Yu; Shengjian Lu; Lujie Zhang; Senmiao Zhu; Zhonghao Yu; Tian Xia; Yikui Zhang; Haoliang Huang; WenHao Jiang; Si Zhang; Lanfang Sun; Qian Ye; Jiaying Sun; Hui Zhu; Pingping Huang; Huifeng Hong; Shuaishuai Yu; Wenjie Li; Danni Ai; Jingfan Fan; Wentao Li; Hong Song; Lei Xu; Xiwen Chen; Tongke Chen; Meng Zhou; Jingxing Ou; Jian Yang; Wei Li; Yang Hu; Wencan Wu
Journal:  Elife       Date:  2022-03-30       Impact factor: 8.713

5.  Hypothermic treatment after computer-controlled compression in minipig: A preliminary report on the effect of epidural vs. direct spinal cord cooling.

Authors:  Monika Zavodska; Jan Galik; Martin Marsala; Stefania Papcunova; Jaroslav Pavel; Eniko Racekova; Marcela Martoncikova; Igor Sulla; Miroslav Gajdos; Imrich Lukac; Jozef Kafka; Valent Ledecky; Igor Sulla; Peter Reichel; Alexandra Trbolova; Igor Capik; Katarina Bimbova; Maria Bacova; Andrea Stropkovska; Alexandra Kisucka; Dana Miklisova; Nadezda Lukacova
Journal:  Exp Ther Med       Date:  2018-10-05       Impact factor: 2.447

6.  Novel dry cryotherapy system for cooling the equine digit.

Authors:  Jessica Morgan; Darko Stefanovski; Margret Lenfest; Sraboni Chatterjee; James Orsini
Journal:  Vet Rec Open       Date:  2018-01-07

Review 7.  Promising neuroprotective strategies for traumatic spinal cord injury with a focus on the differential effects among anatomical levels of injury.

Authors:  Antigona Ulndreaj; Anna Badner; Michael G Fehlings
Journal:  F1000Res       Date:  2017-10-30

8.  Cold Shock Induced Protein RBM3 but Not Mild Hypothermia Protects Human SH-SY5Y Neuroblastoma Cells From MPP+-Induced Neurotoxicity.

Authors:  Hai-Jie Yang; Xiang Shi; Fei Ju; Bei-Ning Hao; Shuang-Ping Ma; Lei Wang; Bin-Feng Cheng; Mian Wang
Journal:  Front Neurosci       Date:  2018-05-03       Impact factor: 4.677

Review 9.  Clinical Neurorestorative Therapeutic Guidelines for Spinal Cord Injury (IANR/CANR version 2019).

Authors:  Hongyun Huang; Wise Young; Stephen Skaper; Lin Chen; Gustavo Moviglia; Hooshang Saberi; Ziad Al-Zoubi; Hari Shanker Sharma; Dafin Muresanu; Alok Sharma; Wagih El Masry; Shiqing Feng
Journal:  J Orthop Translat       Date:  2019-11-11       Impact factor: 5.191

Review 10.  Emerging and Adjunctive Therapies for Spinal Cord Injury Following Acute Canine Intervertebral Disc Herniation.

Authors:  Melissa J Lewis; Nicolas Granger; Nick D Jeffery
Journal:  Front Vet Sci       Date:  2020-10-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.